Learn More about Lumida ETF
Powered by LumidaWealth.com
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
No Result
View All Result
  • Lumida Wealth
  • Lumida Ledger
  • LUMIDA ETF
  • About Us
Home News Macro

China Denies Breaking Trade Truce as U.S.-China Tensions Escalate

by Team Lumida
June 2, 2025
in Macro
Reading Time: 4 mins read
A A
0
China’s Manufacturing Powerhouse Faces Domestic Struggles: What It Means for Global Investors

"MY ROAD : FLAG OF CHINA" by Lαin is licensed under CC BY-NC-ND 2.0

Share on TelegramShare on TwitterShare on FacebookShare on LinkedinShare on Whatsapp

Key Takeaways:

Powered by lumidawealth.com

  • China rejected President Trump’s accusations of violating a trade truce, claiming it upheld the Geneva consensus while accusing the U.S. of undermining the agreement with restrictive measures.
  • Tensions have flared over issues such as U.S. export controls on AI chips, visa restrictions for Chinese students, and China’s rare-earth mineral exports.
  • Trump reiterated his accusations, stating he plans to discuss the matter with Chinese President Xi Jinping.
  • The breakdown in progress toward a deal has rattled markets, with Hong Kong’s Hang Seng Index falling 2.2% and the Hang Seng Tech Index dropping 2.4%.

What Happened?

China’s Commerce Ministry pushed back against President Trump’s claims that Beijing violated a trade truce reached in mid-May during talks in Geneva. The agreement had temporarily lowered tariffs, offering a brief reprieve to global markets.

In a statement, China accused the U.S. of undermining the consensus by introducing “discriminatory and restrictive measures,” including export controls on AI chips and visa revocations for Chinese students. Trump, however, accused China of violating “a big part of the agreement” and expressed his intention to discuss the issue with Chinese President Xi Jinping.

The renewed tensions have dampened optimism for a lasting trade deal, with markets reacting negatively. Chinese stocks in Hong Kong fell sharply, led by declines in the Hang Seng Index and Hang Seng Tech Index.


Why It Matters?

The re-escalation of U.S.-China trade tensions highlights the fragility of the temporary truce and the challenges in reaching a lasting agreement. Key issues, such as technology export controls and rare-earth mineral exports, remain contentious, further complicating negotiations.

The market reaction underscores the economic stakes of the ongoing trade dispute. Declines in Chinese equities reflect investor concerns about the potential for prolonged uncertainty and its impact on global trade and economic growth.

Trump’s accusations and China’s counterclaims also signal a deepening mistrust between the two superpowers, raising questions about the feasibility of resolving broader geopolitical and economic tensions.


What’s Next?

President Trump’s planned discussion with Chinese President Xi Jinping will be closely watched for signs of progress or further escalation. Meanwhile, markets will monitor developments in U.S.-China relations, including potential retaliatory measures from Beijing.

Investors will also keep an eye on the impact of U.S. export controls and visa restrictions, as well as China’s response to Trump’s threat to double tariffs on steel and aluminum imports. The outcome of these disputes will shape the trajectory of global markets and trade dynamics in the coming months.

Source
Tags: China
Previous Post

Corporate Pension Funds Shift Strategies Amid Full Funding, Impacting Bonds and Private Equity

Next Post

Sanofi to Acquire Blueprint Medicines in $9.5 Billion Deal to Boost Immunology Portfolio

Recommended For You

Trump–Xi Truce Trades Rare-Earth Relief for Concessions, Easing Supply-Risk for U.S. Industry

by Team Lumida
6 hours ago
Trump–Xi Truce Trades Rare-Earth Relief for Concessions, Easing Supply-Risk for U.S. Industry

Key Takeaways Powered by lumidawealth.com Trump says Beijing will ease rare-earth export controls, removing a major supply chokepoint for EVs, wind, and defense. Concessions appear reciprocal: tariff relief and...

Read more

Fed to Cut Bank Supervision Staff by 30%, Signaling Softer Oversight

by Team Lumida
6 hours ago
Market Watch: Fed Holds Rates, Hints at September Cut”

Key Takeaways Powered by lumidawealth.com Headcount in Supervision & Regulation to drop from ~500 to ~350 by end-2026 via attrition and voluntary separations. Vice Chair for Supervision Michelle Bowman...

Read more

China’s PMI Slips to 49.0: Manufacturing Contraction Deepens Despite Services Stabilizing

by Team Lumida
6 hours ago
China’s Bold Economic Moves: What You Need to Know Now

Key Takeaways Powered by lumidawealth.com Official manufacturing PMI fell to 49.0 in October (Sep: 49.8), seventh straight month below 50. Export orders dropped to 45.9; production slid to 49.7;...

Read more

Trump Leans on Foreign Policy Wins as Domestic Pressures Mount

by Team Lumida
6 hours ago
Trump Tariffs Leave Key Questions on China Supply Chain Rules Unanswered

Key Takeaways Powered by lumidawealth.com Six-day Asia trip yielded trade pledges and investment MOUs; White House touts up to $2T in prospective commitments. Immediate U.S. backdrop: month-long government shutdown,...

Read more

Trump Cuts China Tariffs to Spur Fentanyl Crackdown and Trade De-escalation

by Team Lumida
1 day ago
Trump Announces 25% Tariffs on Mexico and Canada, Targeting Border Security and Trade

Key Takeaways Powered by lumidawealth.com U.S. lowers select China tariffs tied to fentanyl to 10% from 20%, nudging average tariffs on most Chinese imports to ~45% from ~55%. China...

Read more

Fed Seen Cutting Rates, But With No Added Signal

by Team Lumida
2 days ago
Why Mortgage Servicers Are Thriving Amid High Rates

Key Takeaways Fed expected to cut rates 25 bps Wednesday (2 p.m. decision, Powell presser 30 min later); Chair Powell likely to offer little guidance as growing divide...

Read more

After Demolishing the U.S.-China Relationship, Trump Is Rebuilding It His Way

by Team Lumida
2 days ago
Trump Tariffs Leave Key Questions on China Supply Chain Rules Unanswered

Key Takeaways Powered by lumidawealth.com U.S.-China trade negotiators reached framework agreement in Kuala Lumpur Sunday, setting stage for Trump-Xi deal Thursday in South Korea; transactional truce involves China resuming...

Read more

Trump Hails Golden Era in Japan Relations

by Team Lumida
2 days ago
Why Berkshire’s Latest Yen Bond Sale Could Ignite the Japanese Market

Key Takeaways Powered by lumidawealth.com Trump and new PM Takaichi pledged "golden age" of U.S.-Japan cooperation aboard USS George Washington; Takaichi vowed to boost defense spending to 2% of...

Read more

Rare Earths Producers Look to US-Led Boom to Blunt China’s Power

by Team Lumida
3 days ago
Rare Earths Producers Look to US-Led Boom to Blunt China’s Power

Key Takeaways Powered by lumidawealth.com US rare-earth magnet producers (Noveon, MP Materials) see surging demand after China's April export curbs; Adamas says US capacity could offset imports by 2028...

Read more

China Analysts Expect US to Ease Export Curbs for Magnet Relief

by Team Lumida
3 days ago
China’s Financial Overhaul: Xi’s Strategy to Rebalance $9.1 Trillion Debt Crisis

Key Takeaways Powered by lumidawealth.com Chinese analysts expect US to dial back Sept. 29 "affiliates rule" (restricting chip sales to subsidiaries of blacklisted Chinese firms like Huawei) in exchange...

Read more
Next Post
Sanofi to Acquire Blueprint Medicines in $9.5 Billion Deal to Boost Immunology Portfolio

Sanofi to Acquire Blueprint Medicines in $9.5 Billion Deal to Boost Immunology Portfolio

AI Investment Boom: How Tech Giants Are Leading the Charge

AI Models Show Alarming Ability to Evade Human Control, Highlighting Urgent Need for Alignment Research

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Related News

Nordstrom Family Secures $4 Billion Deal to Take Retailer Private

Nordstrom Family Secures $4 Billion Deal to Take Retailer Private

December 23, 2024
Credit Markets Aren’t Flashing Recession Fears—But That Could Be the Problem

Credit Markets Aren’t Flashing Recession Fears—But That Could Be the Problem

April 17, 2025
US Treasury Secretary Bessent: Terming Out US Debt Is “A Long Way Off”

Treasury Secretary Bessent Urges Federal Reserve to Cut Rates by 150-175 Basis Points

August 14, 2025

Subscribe to Lumida Ledger

Browse by Category

  • Lifestyle
    • Family Office
    • Health and Longevity
    • Next Gen Wealth
    • Trust, Tax, and Estate
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Latest
    • Macro
    • Markets
    • Real Estate
  • Research
    • Trackers
  • Themes
    • Aging & Longevity
    • AI
    • Biotech
    • CRE
    • Cybersecurity
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
    • Software
Facebook Twitter Instagram Youtube TikTok LinkedIn
Lumida News

Premium insights to help you invest beyond the ordinary. Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser

CATEGORIES

  • Aging & Longevity
  • AI
  • Alt Assets
  • Biotech
  • CRE
  • Crypto
  • Cybersecurity
  • Digital Assets
  • Equities
  • Family Office
  • Health and Longevity
  • Latest
  • Legacy Brands
  • Lifestyle
  • Macro
  • Markets
  • News
  • Next Gen Wealth
  • Nuclear Renaissance
  • Private Credit
  • Real Estate
  • Software
  • Themes
  • Trackers
  • Trust, Tax, and Estate

BROWSE BY TAG

AI AI chips AI demand Amazon Apple Artificial Intelligence Banking Bitcoin China Commercial Real Estate CPI Crypto Donald Trump EARNINGS ELON MUSK ETF Ethereum Federal Reserve financial services generative AI Goldman Sachs Google India Inflation Interest Rates Investment Strategy Japan Jerome Powell JPMorgan Markets Meta Microsoft Nasdaq Nvidia OpenAI private equity S&P 500 SEC Semiconductor stock market Tech Stocks tesla Trump Wells Fargo Whale Watch

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018

No Result
View All Result
  • Home
  • Earnings
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018